Urothelial cancer
1 – 50 of 100
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Cumulative incidence of and risk factors for BCG infection after adjuvant BCG instillations
2024) In BJU International(
- Contribution to journal › Article
-
Mark
International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer : Working Group 3: Subcategorization of T1 Bladder Cancer
(
- Contribution to journal › Article
-
Mark
Metastasis and recurrence patterns in the molecular subtypes of urothelial bladder cancer
(
- Contribution to journal › Article
-
Mark
Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostat-ectomy. A nationwide population-based study
(
- Contribution to journal › Article
-
Mark
Cystectomy for bladder cancer in Sweden - short-term outcomes after centralization
(
- Contribution to journal › Article
-
Mark
Violation of onco-surgical principles is associated with survival outcomes in upper tract urothelial carcinomas after radical nephroureterectomy
(
- Contribution to journal › Article
-
Mark
Distinct Infiltration of T Cell Populations in Bladder Cancer Molecular Subtypes
(
- Contribution to journal › Article
-
Mark
Urorektal fistulering efter rektalbiopsier vid strålproktopati
(
- Contribution to journal › Article
- 2023
-
Mark
Health-related quality of life prior to and 1 year after radical cystectomy evaluated with FACT-G and FACT-VCI questionnaires
(
- Contribution to journal › Article
-
Mark
What is a Bladder Cancer Molecular Subtype?
(
- Contribution to journal › Scientific review
-
Mark
Location of Retroperitoneal Lymph Node Metastases in Upper Tract Urothelial Carcinoma : Results from a Prospective Lymph Node Mapping Study
(
- Contribution to journal › Article
-
Mark
The current use of the EORTC QLQ-NMIBC24 and QLQ-BLM30 questionnaires for the assessment of health-related quality of life in bladder cancer patients : a systematic review
(
- Contribution to journal › Scientific review
-
Mark
Quinolone Prophylaxis in Conjunction with Bacillus Calmette-Guérin Instillations for Bladder Cancer : Time To Reconsider the Evidence and Open the Quinolone Box?
2023) In European Urology Focus(
- Contribution to journal › Scientific review
-
Mark
Tumor Biomarkers for Bacillus Calmette-Guérin Response : What We Get Is Not What We Want
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Urodrill - a novel MRI-guided endoscopic biopsy technique to sample and molecularly classify muscle-invasive bladder cancer without fractionating the specimen during transurethral resection
(
- Contribution to journal › Article
-
Mark
International Opinions on Grading of Urothelial Carcinoma : A Survey Among European Association of Urology and International Society of Urological Pathology Members
(
- Contribution to journal › Article
-
Mark
Latent heterogeneity of muscle-invasive bladder cancer in patient characteristics and survival : A population-based nation-wide study in the Bladder Cancer Data Base Sweden (BladderBaSe)
(
- Contribution to journal › Article
-
Mark
UROSCAN and UROSCANSEQ : a large-scale multicenter effort towards translation of molecular bladder cancer subtypes into clinical practice–from biobank to RNA-sequencing in real time
(
- Contribution to journal › Article
-
Mark
Restoring tumor immunogenicity with dendritic cell reprogramming
(
- Contribution to journal › Article
-
Mark
Urosymphyseal fistula after pelvic radiotherapy in a tertial referral centre - a rare entity with significant comorbidity requiring multidisciplinary management
(
- Contribution to journal › Article
-
Mark
The Lund taxonomy for bladder cancer classification – from gene expression clustering to cancer cell molecular phenotypes, and back again
(
- Contribution to journal › Scientific review
-
Mark
Preoperative upper tract invasive diagnostic modalities are associated with intravesical recurrence following surgery for upper tract urothelial carcinoma : A population-based study
(
- Contribution to journal › Article
-
Mark
Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer
(
- Contribution to journal › Article
-
Mark
Re : Alexander Cox, Niklas Klümper, Johannes Stein, et al. Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.03.020
(
- Contribution to journal › Letter
-
Mark
FDG-PET/CT for lymph node staging prior to radical cystectomy
(
- Contribution to journal › Article
-
Mark
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma : 2023 Update
(
- Contribution to journal › Scientific review
- 2022
-
Mark
A comparison of rule-based and centroid single-sample multiclass predictors for transcriptomic classification
(
- Contribution to journal › Article
-
Mark
Swedish National Guidelines on Urothelial Carcinoma : 2021 update on non-muscle invasive bladder cancer and upper tract urothelial carcinoma
(
- Contribution to journal › Article
-
Mark
Cost Effectiveness of the Use of Prophylactic Mesh To Prevent Parastomal Hernia After Urinary Diversion with an Ileal Conduit
(
- Contribution to journal › Article
-
Mark
The Lund Molecular Taxonomy Applied to Non-Muscle-Invasive Urothelial Carcinoma
(
- Contribution to journal › Article
-
Mark
Anorectal dysfunction after radical cystectomy for bladder cancer
(
- Contribution to journal › Article
-
Mark
Immunohistochemical Assays for Bladder Cancer Molecular Subtyping : Optimizing Parsimony and Performance of Lund Taxonomy Classifiers
(
- Contribution to journal › Article
-
Mark
Patient-Derived Bladder Cancer Organoid Models in Tumor Biology and Drug Testing : A Systematic Review
(
- Contribution to journal › Scientific review
-
Mark
Standardized care pathways for patients with suspected urinary bladder cancer : the Swedish experience
(
- Contribution to journal › Article
-
Mark
Interaction between blood pressure and genetic risk score for bladder cancer, and risk of urothelial carcinoma in men
(
- Contribution to journal › Article
-
Mark
Restoring tumor immunogenicity with dendritic cell reprogramming
(
- Contribution to journal › Published meeting abstract
-
Mark
Reply to Joep J. de Jong and Ewan A. Gibb's Letter to the Editor re: Gottfrid Sjödahl, Johan Abrahamsson, Karin Holmsten, et al. Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes. Eur Urol. 2022;81:316-7. Neoadjuvant Chemotherapy Response in Muscle-invasive Bladder Cancer: Differences in Intrinsic Biology or Subtyping Nomenclature?
(
- Contribution to journal › Letter
-
Mark
Molecular pathology of the non-luminal Ba/Sq-like and Sc/NE-like classes of urothelial tumours : An integrated immunohistochemical analysis
(
- Contribution to journal › Article
-
Mark
The Urothelial Transcriptomic Response to Interferon Gamma : Implications for Bladder Cancer Prognosis and Immunotherapy
(
- Contribution to journal › Article
-
Mark
Immunohistochemistry subtyping of urothelial carcinoma is feasible in the daily practice
(
- Contribution to journal › Article
-
Mark
Robot-assisted nephroureterectomy for upper tract urothelial carcinoma—feasibility and complications : a single center experience
(
- Contribution to journal › Article
-
Mark
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)
(
- Contribution to journal › Scientific review
-
Mark
Diagnostic and prognostic implications of a three-antibody molecular subtyping algorithm for non-muscle invasive bladder cancer
(
- Contribution to journal › Article
-
Mark
Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes
(
- Contribution to journal › Article
-
Mark
A quantitative polymerase chain reaction based method for molecular subtype classification of urinary bladder cancer—Stromal gene expressions show higher prognostic values than intrinsic tumor genes
(
- Contribution to journal › Article
-
Mark
Urostomal ileal conduit complications in association with abdominal wall mesh implantation
(
- Contribution to journal › Article
-
Mark
Molecular Subtypes as a Basis for Stratified Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer—A Narrative Review
(
- Contribution to journal › Scientific review
-
Mark
Re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy Have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029 : A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with Curative Intent: Induction Versus Neoadjuvant Chemotherapy
(
- Contribution to journal › Letter
-
Mark
Risk of bladder cancer death in patients younger than 50 with non-muscle-invasive and muscle-invasive bladder cancer
(
- Contribution to journal › Article
- 2021
-
Mark
Personalized medicine for bladder cancer
(
- Contribution to journal › Article